sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> xerostomia dry mouth therapeutics market

report

Xerostomia (Dry Mouth) Therapeutics Market, by Type (OTC, Prescription), Product (Salivary Stimulants, Salivary Substitutes, Dentifrices) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC424 November 2017 100+ FREE 10% CUSTOMIZATION

Xerostomia is a medical condition of dry mouth resulting from reduced or absent saliva flow. It is not a disease; however, it might be a symptom of a medical condition or sometimes even a side effect of some kind of medication. It is more common in old aged people and in people who tend to breathe through their mouth. Any reason which can lead to hypo-functioning of the salivary glands can give rise to this problem. Procedures like chemotherapy and radiotherapy can also affect the salivary glands and condition of dry mouth. This report studies the current and future aspects of the Xerostomia Therapeutics market.

The report on the global xerostomia (dry mouth) therapeutics market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The xerostomia therapeutics market is growing at a rapid pace during the forecasted period mainly because of increasing usage of medication and adoption of treatment procedures like chemotherapy and radiotherapy. The rise in geriatric population is also promoting the market growth.
  • Easy availability of cost-effective medications is one of the major market driving factors. Increasing incidences of diseases like cancer, hypertension, diabetes, or psychological disorders accounts for usage of prescribed medications which leads to dry mouth; this feature is contributing towards the growth of xerostomia therapeutics market.

The global xerostomia therapeutics market is divided into four major geographical segments which are North America, Europe, Asia-Pacific, and Rest of the World (RoW). The North America region holds the highest market share and contributes the highest revenue. The region continues to dominate the global IVF devices and consumables market during the forecasted period because of increasing incidences of diseases that lead to dry mouth, and rising usage of prescribed medications. Next in line is the Asia Pacific region which is witnessing a rapid market growth due to rise in geriatric population and increase in usage of prescribed medication. In addition, there is rise in awareness regarding the health issues and medicine side effects which is also boosting the market growth further.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s xerostomia (dry mouth) therapeutics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the xerostomia (dry mouth) therapeutics market by the following segments:

  • Xerostomia (Dry Mouth) Therapeutics Market, by Type
    • OTC
    • Prescription
  • Xerostomia (Dry Mouth) Therapeutics Market, by Product
    • Salivary Stimulants
    • Salivary Substitutes
    • Dentifrices

KEY MARKET PLAYERS

Key players in the xerostomia (dry mouth) therapeutics market include:

  • Acacia Pharma
  • Parnell Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Church & Dwight Co., Inc.
  • Lupin
  • Sun Pharmaceutical Industries, Ltd.
  • Hikma Pharmaceuticals PLC
  • Pendopharm
  • OraCoat

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Pulse Oximeters Market, by Product (Standalone Device And Multiparameter Device), Application (Hospital Care And Alternative Care) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
  5. XEROSTOMIA (DRY MOUTH) THERAPEUTICS MARKET, BY TYPE
    1. Segment Share
    2. By Type
      1. OTC
      2. Prescription
  6. XEROSTOMIA (DRY MOUTH) THERAPEUTICS MARKET, BY PRODUCT
    1. Segment Share
    2. By Product
      1. Salivary Stimulants
      2. Salivary Substitutes
      3. Dentifrices
  7. XEROSTOMIA (DRY MOUTH) THERAPEUTICS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Type
      3. By Product
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Type
      3. By Product
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type
      3. By Product
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Type
      3. By Product
  8. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
    2. Key Innovators
  9. KEY MARKET PLAYERS
    1. Acacia Pharma
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Parnell Pharmaceuticals, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. GlaxoSmithKline plc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Church & Dwight Co., Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Lupin
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Sun Pharmaceutical Industries, Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Hikma Pharmaceuticals PLC.
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Pendopharm
      1. Overview
      2. Key Strategies
      3. Key Developments
    10. OraCoat
      1. Overview
      2. Key Strategies
      3. Key Developments
  10. SCALAR 360 DEGREE MARKET PERSPECTIVE
  11. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us